Schering-Plough taps China innovation through HUYA
This article was originally published in Scrip
Schering-Ploughis looking to access China's growing innovative capability through a tie-up with HUYA Bioscience International. HUYA will exclusively provide to the US major's Organon subsidiary drug development candidates sourced from its network of Chinese research alliances.
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Japanese major builds presence in novel device technology beyond its conventional therapeutics as looks towards a more holistic future of care.